Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Novavax (DE:NVV1)
XETRA:NVV1
Holding DE:NVV1?
Track your performance easily
Novavax (NVV1) Ownership Overview
0.24% Insiders
11.47% Mutual Funds
13.51% Other Institutional Investors
17.96% ETFs
56.82% Public Companies and
Individual Investors
The ownership structure of Novavax (DE:NVV1) stock is a mix of institutional, retail, and individual investors. Approximately 42.94% of the company’s stock is owned by Institutional Investors, 0.24% is owned by Insiders, and 56.82% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Jun 25, 2024 | James F. Young Director | xxxxxxxxxxxxx | $105675 |
| Jun 21, 2024 | James F. Young Director | xxxxxxxxxxxxx | $102881 |
| Jun 20, 2024 | Filip Dubovsky President, R&d | xxxxxxxxxxxxx | $201164 |
| May 15, 2024 | Filip Dubovsky President, R&d | xxxxxxxxxxxxx | $657637 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Sep 30, 2024 | xxxxxxxxxxxxx | $202080 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $701773 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $922760 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $1060920 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 14,518,541 | Institution | 9.06% | 132,017,093 | |
| 11,628,048 | Institution | 7.26% | 105,733,840 | |
| 7,175,801 | Institution | 4.48% | 65,249,558 | |
| 4,352,646 | Institution | 2.72% | 39,578,610 | |
| 2,224,319 | Institution | 1.39% | 20,225,733 | |
| 1,595,129 | Institution | 1.00% | 14,504,508 | |
| 1,449,941 | Institution | 0.91% | 13,184,314 | |
| 1,400,000 | Institution | 0.87% | 12,730,200 | |
| 870,387 | Institution | 0.54% | 7,914,429 | |
| 790,798 | Institution | 0.49% | 7,190,726 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 11,628,048 | Institution | 7.26% | 105,733,840 | |
| 1,595,129 | Institution | 1.00% | 14,504,508 | |
| 1,449,941 | Institution | 0.91% | 13,184,314 | |
| 708,336 | Institution | 0.44% | 6,440,899 | |
| 526,327 | Institution | 0.33% | 4,785,891 | |
| 460,538 | Institution | 0.29% | 4,187,672 | |
| 421,238 | Institution | 0.26% | 3,830,317 | |
| 315,397 | Institution | 0.20% | 2,867,905 | |
| 307,937 | Institution | 0.19% | 2,800,071 | |
| 154,592 | Institution | 0.10% | 1,405,705 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Novavax (DE:NVV1)?
According to the latest TipRanks data, approximately 13.51% of the company's stock is held by institutional investors, 0.24% is held by insiders, and 56.82% is held by retail investors.
What percentage of Novavax (DE:NVV1) stock is held by institutional investors?
According to the latest TipRanks data, approximately 13.51% of Novavax (DE:NVV1) stock is held by institutional investors.
What percentage of Novavax (DE:NVV1) stock is held by retail investors?
According to the latest TipRanks data, approximately 56.82% of Novavax (DE:NVV1) stock is held by retail investors.
Who owns the most shares of Novavax (DE:NVV1)?
Vanguard owns the most shares of Novavax (DE:NVV1).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.